Answer
Angeliq is indicated for osteoporosis prevention in postmenopausal women at high risk of future fractures who are intolerant of, or have contraindications to, other medicines approved for osteoporosis prevention; experience treating women older than 65 years is limited.
Sources for this answer
- Angeliq 1 mg/2 mg film-coated tabletsBayer plc · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked